Kovitz Investment Group Partners
DERM icon

Kovitz Investment Group Partners’s Journey Medical DERM Stock Holding History

Kovitz Investment Group Partners’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-21,710
Closed -$155K – 642
2025
Q3 		$155K Hold
21,710
– – ﹤0.01% 1355
2025
Q2 		$156K Hold
21,710
– – ﹤0.01% 1303
2025
Q1 		$128K Sell
21,710
-3,000
-12% -$14.8K ﹤0.01% 1203
2024
Q4 		$96.6K Buy
24,710
+13,105
+113% +$71.6K ﹤0.01% 1203
2024
Q3 		$65.6K Buy
+11,605
New +$59.8K ﹤0.01% 995

Other funds holding DERM

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Kovitz Investment Group Partners's DERM Position: Q4 2025 in Review

Kovitz Investment Group Partners sold out of Journey Medical (DERM) in Q4 2025, closing a stake of 21,710 shares — an estimated $155K sold.

Kovitz Investment Group Partners first reported a position in DERM in Q3 2024 and held it in 5 quarters. The position peaked at $156K in Q2 2025. 77 funds tracked by Wall St. Rank hold DERM as of Q4 2025.

  • Kovitz Investment Group Partners reported no remaining Journey Medical position as of Q4 2025 after selling out during the quarter.
  • Kovitz Investment Group Partners sold 21,710 Journey Medical shares in Q4 2025, an estimated $155K.
  • Kovitz Investment Group Partners first reported a position in Journey Medical in Q3 2024 and held it in 5 quarters.
  • Kovitz Investment Group Partners's Journey Medical position peaked at $156K in Q2 2025.
  • 77 funds tracked by Wall St. Rank held Journey Medical as of Q4 2025.

Based on Kovitz Investment Group Partners's 13F filing for Q4 2025, filed 20 Feb 2026.